Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis

被引:7
|
作者
Chen, Yiwang [1 ,2 ,3 ]
Ji, Lecai [3 ]
Liu, Qingyun [1 ,2 ,4 ]
Li, Jinli [3 ]
Hong, Chuangyue [3 ]
Jiang, Qi [1 ,2 ,3 ]
Gan, Mingyu [5 ]
Takiff, Howard E. [6 ,7 ,8 ]
Yu, Weiye [3 ]
Tan, Weiguo [3 ]
Gao, Qian [1 ,2 ,3 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
[3] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China
[4] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[5] Fudan Univ, Mol Med Ctr, Childrens Hosp, Shanghai, Peoples R China
[6] Inst Pasteur, Integrated Mycobacterial Pathogen Unit, Paris, France
[7] Shenzhen Nanshan Ctr Chron Dis Control, Dept TB Control & Prevent, Shenzhen, Peoples R China
[8] Inst Venezolano Invest Cient, Caracas, Venezuela
来源
JOURNAL OF INFECTIOUS DISEASES | 2021年 / 224卷 / 05期
关键词
multiple lesions; heteroresistance; multidrug- resistant tuberculosis; whole genome sequencing; underestimation; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE;
D O I
10.1093/infdis/jiab011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis heteroresistance, in which only a fraction of the bacteria in a patient with tuberculosis contains drug-resistant mutations, has been a rising concern. However, its origins and prevalence remain elusive. Here, whole-genome sequencing was performed on 83 serial isolates from 31 patients with multidrug-resistant tuberculosis, and heteroresistance was detected in isolates from 21 patients (67.74%). Heteroresistance persisted in the host for long periods, spanning months to years, and was associated with having multiple tubercular lesions. Our findings indicate that heteroresistance is common and persistent in patients with multidrug-resistant tuberculosis and may affect the success of their treatment regimens.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 50 条
  • [1] Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain
    Gavin, Patricia
    Iglesias, Maria Jose
    Jimenez, Maria Soledad
    Rodriguez-Valin, Elena
    Ibarz, Daniel
    Lezcano, Maria Antonia
    Revillo, Maria Jose
    Martin, Carlos
    Samper, Sofia
    [J]. INFECTION GENETICS AND EVOLUTION, 2012, 12 (04) : 701 - 710
  • [2] Long-term treatment outcomes in patients with multidrug-resistant tuberculosis
    Maier, Christina
    Chesov, Dumitru
    Schaub, Dagmar
    Kalsdorf, Barbara
    Andres, Sonke
    Friesen, Inna
    Reimann, Maja
    Lange, Christoph
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (06) : 751 - 757
  • [3] Long-term results of multidrug-resistant tuberculosis treatment.
    Chernokhaeva, Irina
    Pavlova, Maria
    Starshinova, Anna
    Sapozhnikova, Nadezhda
    Archakova, Liudmila
    Istomina, Evgenia
    Ershova, Elena
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands
    Geerligs, WA
    van Altena, R
    de Lange, WCM
    van Soolingen, D
    van der Werf, TS
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (08) : 758 - 764
  • [5] Long-term follow-up for multidrug-resistant tuberculosis
    Shin, SS
    Furin, JJ
    Alcántara, F
    Bayona, J
    Sánchez, E
    Mitnick, CD
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (04) : 687 - 688
  • [6] Impact of Diabetes on Treatment Outcomes and Long-Term Survival in Multidrug-Resistant Tuberculosis
    Kang, Young Ae
    Kim, Song Yee
    Jo, Kyung-Wook
    Kim, Hee Jin
    Park, Seung-Kyu
    Kim, Tae-Hyung
    Kim, Eun Kyung
    Lee, Ki Man
    Lee, Sung Soon
    Park, Jae Seuk
    Koh, Won-Jung
    Kim, Dae Yun
    Shim, Tae Sun
    [J]. RESPIRATION, 2013, 86 (06) : 472 - 478
  • [7] Long-term survival of patients with multidrug-resistant tuberculosis according to treatment outcomes
    Kwak, Nakwon
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Yim, Jae-Joon
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (07) : 843 - 845
  • [8] Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
    Wells, Charles D.
    Gupta, Rajesh
    Hittel, Norbert
    Geiter, Lawrence J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1498 - 1501
  • [9] Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
    Guglielmetti, Lorenzo
    Jaspard, Marie
    Le Du, Damien
    Lachatre, Marie
    Marigot-Outtandy, Dhiba
    Bernard, Christine
    Veziris, Nicolas
    Robert, Jerome
    Yazdanpanah, Yazdan
    Caumes, Eric
    Frechet-Jachym, Mathilde
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [10] Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis
    Operario, Darwin J.
    Koeppel, Alexander F.
    Turner, Stephen D.
    Bao, Yongde
    Pholwat, Suporn
    Banu, Sayera
    Foongladda, Suporn
    Mpagama, Stellah
    Gratz, Jean
    Ogarkov, Oleg
    Zhadova, Svetlana
    Heysell, Scott K.
    Houpt, Eric R.
    [J]. PLOS ONE, 2017, 12 (05):